1.Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma

Su, LQ, Luo, HY, Yan     More...

Su, LQ, Luo, HY, Yan, YL, Yang, ZQ, Lu, JA, Xu, DQ, Du, LJ, Liu, J, Yang, GH, Chi, H     Less

FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2024, Volume 15,

收錄情况： WOS SCOPUS

WOS核心合集引用: 13  2024影響因子:  4.8  发表年影響因子:  4.8 

2.Mitochondrial inhibitors: a new horizon in breast cancer therapy

Yan, YL, Li, SJ, Su,     More...

Yan, YL, Li, SJ, Su, LQ, Tang, XR, Chen, XY, Gu, X, Yang, GH, Chi, H, Huang, SK     Less

FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2024, Volume 15,

收錄情况： WOS SCOPUS

WOS核心合集引用: 14  2024影響因子:  4.8  发表年影響因子:  4.8 

3.Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy

Li, YY, Cai, HB, Yan     More...

Li, YY, Cai, HB, Yang, JY, Xie, XX, Pei, SB, Wu, YF, Zhang, JH, Song, GB, Zhang, JY, Zhang, QH, Chi, H, Yang, GH     Less

FRONTIERS IN PHARMACOLOGY[1663-9812], Published 2023, Volume 14,

收錄情况： WOS SCOPUS

WOS核心合集引用: 18  2024影響因子:  4.8  发表年影響因子:  4.4